Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Status: Opinion
Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Status: Opinion
Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Status: Opinion
Training and resources for patients and consumers
Republic of Korea
Human medicines European public assessment report (EPAR): Pramipexole Teva, pramipexole, Date of authorisation: 18/12/2008, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of authorisation: 23/03/2015, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Emend, aprepitant, Date of authorisation: 11/11/2003, Revision: 31, Status: Authorised
Emend (aprepitant) supply shortage
Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Accord, sitagliptin,metformin hydrochloride, Date of authorisation: 22/07/2022, Revision: 2, Status: Authorised